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a b s t r a c t
Aim: We aimed to determine the relative frequency of febrile convulsion in children with
major thalassemia to theorize that higher serum iron levels could reduce the incidence of
febrile convulsion. Background: Febrile convulsion is the most common type of seizure in
childhood that its causes are not fully understood. However, some risk factors have been
cited such as the serum iron level. Materials and methods: Three hundred and ﬁfty-nine
children aged more than 5 years with major thalassemia who were receiving blood were
enrolled as the case group. The control group consisted of 357 children without thalasse-
mia aged 4–7 years (151 boys, 206 girls) who were referred to healthcare centers for routine
health monitoring. Included data were the history of febrile convulsion, age of onset and
type and the frequency of convulsions. Results: Children in control group signiﬁcantly
experienced more febrile convulsions than thalassemic children [4/359 (1.1%) in the thalas-
semic children and 14/357 (3.9%) in the control group had experienced febrile convulsions
(P = 0.017)]. Conclusion: The frequency of febrile convulsion in children with major thalas-
semia is less than that of normal children. Children with thalassemia major may have
higher serum levels of iron and such high serum iron levels might have a protective role in
the children who have a vulnerability for febrile convulsions.
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Febrile convulsion is the most common type of seizure
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10-year-old children, reaching its peak incidence at 14–18
months of age [1–3]. Although its mortality and morbidity
rates are low, but many parents are concerned about the
recurrence of seizures [1–3].tan Medical, Educational, and Research Center, Ahvaz Jundisha-
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not fully understood. Genetic studies have shown a relation
between the genes on chromosomes 8 and 19 and suscepti-
bility to this entity [2]. Some studies have assessed the
effect of microelements deﬁciency, and recently a few
studies such as one performed in Iran have focused on iron
deﬁciency, and have recommended the use of iron supple-
ments [4–6]. Two recent studies in Iran and Thailand
mentioned a lower frequency of febrile convulsions in
patients with major thalassemia [7, 8].
In patients who have thalassemia major, iron is accumu-
lated in the body as a result of ineffective erythropoiesis
and frequent blood transfusions. A few studies had reported
lower incidence of febrile seizures in children with major
thalassemia; therefore, iron accumulation might have
a protective or preventive role in the occurrence of febrile
convulsions in patients with major thalassemia [7].
In one study in Thailand on 430 patients with thalassemia
aged 6 months to 10 years, the researchers found that the
frequency of febrile convulsion was 4.4 times lower in
children with thalassemia compared with the general popula-
tion. In the mentioned study, the annual incidence of febrile
convulsion was 1.1/1000 individuals in patients with thalasse-
mia, compared with 4.8 in the normal population [7].
In a study performed in Iran comparing patients with
febrile convulsion and febrile patients without convulsion,
no signiﬁcant association was found between anemia and
the incidence of febrile convulsions [9].
Major thalassemia is more frequent in southwest of Iran
(Khouzestan) than that of the other provinces because of the
more frequency of thalassemia genes in the general popula-
tion and consanguineous marriages in this area of Iran. To
the best of our knowledge, no study has been performed to
measure the frequency of febrile convulsions in patients with
major thalassemia in Khouzestan, southwest Iran. We aimed
to assess the relative frequency of febrile convulsion in
children with major thalassemia comparing to a group of
healthy children to theorize that higher serum levels of Iron
in children with major thalassemia might have a protective
role against febrile convulsions in these children.
Patients and methods
This cross sectional study was performed in Jundishapur
University of Medical Sciences, Ahvaz, southwest Iran from
April 2010 to April 2011.
Data were collected using related questionnaires. We
enrolled 363 patients with major thalassemia over the age
of 5 who referred to the thalassemia clinics of Shafa,
Abuzar, and Naft Hospitals in Ahvaz as the case group. The
patients were conﬁrmed as having major thalassemia based
on their history, medical records, blood tests, and hemoglo-
bin electrophoresis. In the control group, 363 healthy child-
ren with an age range of 4–7 years who had referred to
healthcare centers in Ahvaz for growth monitoring and
vaccination were also selected after informing their parents
about the aims of the study.
A trained nurse interviewed the participants regarding
their demographic information, history of febrile convulsion,age of the initial onset of convulsion, number of recurrent
febrile convulsions, history of febrile convulsions in ﬁrst
degree relatives, familial history of epilepsy, developmental
condition, history of related hospital admission, type of febrile
convulsion, history of anti-convulsant intake, and history of
hypoparathyroidism. A precise history regarding the patients'
febrile convulsion and their medical records was taken.
In order to prevent bias, the control group was selected
from healthy children who had only referred to the health-
care centers for routine growth assessment.
If the patients were admitted to the hospitals, their
medical records were used to diagnose febrile convulsion. If
the medical records were unavailable, febrile convulsion
was conﬁrmed based on a previous diagnosis made by
a pediatrician or family physician.
Febrile convulsion was considered if the seizures were
accompanied by fever and no signs of other diseases such
as meningitis, encephalitis, and colitis or history of psycho-
motor retardation, epilepsy, or brain tumor were present.
In the case group, we included patients with beta thalas-
semia major who had experienced febrile convulsion, neither
have psychomotor retardation nor suffer from meningitis,
encephalitis, and colitis during seizures, with the informed
consent of their parents. Patients whose parents were inca-
pable of remembering the accurate history of convulsions
were excluded from our study. The study protocol conforms
to the ethical guidelines of the 1975 Declaration of Helsinki as
reﬂected in a priori approval by the institution's human
research committee.
Statistical analysis was performed using SPSS version 16.0
statistical software (SPSS, Inc., Chicago, IL). x2, t, and Fisher's
exact tests were used when appropriate. A biostatistician
who was blinded to the study groups performed the statis-
tical analysis.
Results
We enrolled to this study, 363 children aged more than
5 years with major thalassemia (169 boys, 194 girls) who
were receiving blood as the patient group and 363 children
without thalassemia aged 4–7 years (154 boys, 209 girls) who
had referred to healthcare centers for routine health moni-
toring as the control group.
Of the 363 patients with thalassemia major, 4 patients
were excluded from the study because of psychomotor
retardation (PMR), suspected shivering, suspected breath
holding, and history of convulsion at the age of 10 months
and long hospital stay. In the control group, 6 children were
excluded for reasons such as having meningitis (n = 1),
shigellosis (n = 2), and suspected shivering (n = 3).
Among the children with thalassemia major, 4/359 (1.1%)
had a history of febrile convulsion as compared with 14/357
(3.9%) children in the control group (P = 0.017, x2 test). Among
the four children in the case group who had a history of
febrile convulsion, 3 (1.8%) were girls and 1 (0.5%) was a boy
(P = 0.25), compared to 9 (5.8%) boys and 5 (2.4%) girls in the
control group (P = 0.09).
In overall, 18 children had a history of febrile convulsion
in both groups including 12 (66.7%) boys and 6 (33.3%) girls.
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convulsion in both groups was 20.26 (9.1) months (range:
6–36 months). The mean (SD) age of the initial onset of
febrile convulsion in the case and control groups were 22.5
(12.4) and 19.7 (8.4) months, respectively (P = 0.59, t test).
Of the 4 children who had experienced febrile convulsion
in the case group, 3 (75%) had experienced the simple type
of febrile convulsion while 1 (25%) had experienced the
complex type. In the control group, 11 (78.6%) children had
had the simple febrile convulsion, while 3 (21.4%) had had
the complex type (P = 0.99, Fisher's exact test).
Discussion
According to existing evidence, the complex balance bet-
ween the activities of the glutamate-GABA systems plays an
important role in controlling convulsions. Iron deﬁciency
probably reduces the activity of GABA systems leading to
the occurrence of convulsion [7]. Therefore, Iron overload
may reduce the incidence of convulsion by increasing the
activity of the GABA system which is an inhibitory neuro-
transmitter in the brain.
Our results show that the occurrence of convulsion was
signiﬁcantly lower in patients with thalassemia major (1.1%
vs. 3.9% in the case and control groups, respectively) and
this ﬁnding further suggests that children with thalassemia
major may have increased serum iron levels and such
increased serum iron levels may has a protective role
against febrile convulsions.
Our ﬁndings are consistent with previous studies. In
a similar study comparing the occurrence of febrile convul-
sion in children with thalassemia major and healthy con-
trols, the researchers found that the incidence of febrile
convulsion was 2.5 times more in the control group. In the
mentioned study, the frequency of febrile convulsion was
0.9% and 2.3% in the case and control groups, respectively
[8]. In another report, the incidence of febrile convulsion
was 4.4 times higher in the normal population compared
with patients with thalassemia [7].
It is hypothesized that in patients with thalassemia, iron is
accumulated in the body as a result of ineffective erythropoie-
sis and frequent blood transfusions. Therefore, iron accumu-
lation might have a protective and preventive role against the
occurrence of febrile convulsion in patients with major
thalassemia. Some researchers have demonstrated the above
hypothesis by assessing serum iron and ferritin levels in
patients suffering from seizures and those without a history
of seizure. In one study, the researchers found that serum
ferritin levels were signiﬁcantly lower in 75 children with ﬁrst
febrile convulsion compared with age and sex matched
controls suffering febrile illnesses without convulsions [4].
Vaswani and colleagues compared 50 patients aged
6 months to 6 years with ﬁrst febrile convulsion and 50 age-
matched febrile patients without seizure and found that the
serum ferritin levels were signiﬁcantly lower in patients
with ﬁrst febrile seizure [5].
However, Amirsalari and co-workers did not ﬁnd
a signiﬁcant difference in serum ferritin, hemoglobin, and
MCH levels between 9 months to 5-year-old patients withﬁrst seizure and the control group [10]. Moreover, in another
study comparing the plasma ferritin levels in 90 children
with febrile convulsion (case group) and 90 febrile children
without seizure (control group), the researchers did not ﬁnd
a signiﬁcant relation between plasma ferritin and TIBC
levels between the case and control groups [11].
In addition, Momen and colleagues found a positive asso-
ciation between iron deﬁciency and the ﬁrst febrile convulsion
in children in a case–control study [6]. In contrast, a study
comparing 100 febrile patients with 100 febrile patients
without seizure showed no association between anemia and
the incidence of febrile convulsion [9]. We have no deﬁnite
explanation for these discrepancies between studies but
different methodology of studies may explain different results.
Although our study and some other studies indicate the
preventive effect of serum iron levels on the occurrence of
febrile convulsion in children; other controversial reports
from studies with different study design, patients' status,
serum ferritin and zinc levels, and different physiological
conditions have led to inconsistent ﬁndings. Therefore,
further complementary studies need to be performed in
order to accurately determine the role of serum iron in
preventing seizures.
Our study had some limitations. The sample size was
less than the desired amount because the number of
patients with thalassemia major receiving blood transfusion
across Ahvaz was less than the determined number in our
sample size calculation. The other major limit of our study
was that its design was retrospective and therefore we could
not measure the serum iron level at the seizure time to
demonstrate increased or decreased serum iron levels at the
seizure occurrence.
Conclusion
Results of our study indicated that children with major
thalassemia had a less frequency of febrile convulsions than
normal children. Children with thalassemia major may have
increased serum iron levels and such elevated serum iron
levels may have a preventive role against the occurrence of
febrile convulsions.
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